Cargando…
The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction
OBJECTIVES: Time-window bias was described in case–control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466602/ https://www.ncbi.nlm.nih.gov/pubmed/26063569 http://dx.doi.org/10.1136/bmjopen-2015-007866 |
_version_ | 1782376252011708416 |
---|---|
author | Di Martino, Mirko Kirchmayer, Ursula Agabiti, Nera Bauleo, Lisa Fusco, Danilo Perucci, Carlo Alberto Davoli, Marina |
author_facet | Di Martino, Mirko Kirchmayer, Ursula Agabiti, Nera Bauleo, Lisa Fusco, Danilo Perucci, Carlo Alberto Davoli, Marina |
author_sort | Di Martino, Mirko |
collection | PubMed |
description | OBJECTIVES: Time-window bias was described in case–control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. SETTING: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). PARTICIPANTS: Patients discharged after MI in 2006–2007 were enrolled in the cohort and followed through 2009. OUTCOME MEASURE: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. DESIGN: A nested case–control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, β-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). RESULTS: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and β-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for ‘0.5<PDC≤0.75’ and ‘PDC>0.75’ versus ‘0≤PDC≤0.5’. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. CONCLUSIONS: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall. |
format | Online Article Text |
id | pubmed-4466602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-44666022015-06-17 The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction Di Martino, Mirko Kirchmayer, Ursula Agabiti, Nera Bauleo, Lisa Fusco, Danilo Perucci, Carlo Alberto Davoli, Marina BMJ Open Pharmacology and Therapeutics OBJECTIVES: Time-window bias was described in case–control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. SETTING: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). PARTICIPANTS: Patients discharged after MI in 2006–2007 were enrolled in the cohort and followed through 2009. OUTCOME MEASURE: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. DESIGN: A nested case–control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, β-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). RESULTS: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and β-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for ‘0.5<PDC≤0.75’ and ‘PDC>0.75’ versus ‘0≤PDC≤0.5’. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. CONCLUSIONS: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall. BMJ Publishing Group 2015-06-10 /pmc/articles/PMC4466602/ /pubmed/26063569 http://dx.doi.org/10.1136/bmjopen-2015-007866 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Pharmacology and Therapeutics Di Martino, Mirko Kirchmayer, Ursula Agabiti, Nera Bauleo, Lisa Fusco, Danilo Perucci, Carlo Alberto Davoli, Marina The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title | The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title_full | The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title_fullStr | The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title_full_unstemmed | The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title_short | The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
title_sort | impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction |
topic | Pharmacology and Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466602/ https://www.ncbi.nlm.nih.gov/pubmed/26063569 http://dx.doi.org/10.1136/bmjopen-2015-007866 |
work_keys_str_mv | AT dimartinomirko theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT kirchmayerursula theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT agabitinera theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT bauleolisa theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT fuscodanilo theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT peruccicarloalberto theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT davolimarina theimpactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT dimartinomirko impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT kirchmayerursula impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT agabitinera impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT bauleolisa impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT fuscodanilo impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT peruccicarloalberto impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction AT davolimarina impactoftimewindowbiasontheassessmentofthelongtermeffectofmedicationadherencethecaseofsecondarypreventionaftermyocardialinfarction |